An Overview of COVID-19 Medicines in Current Guidelines
An acute respiratory disease caused by a new coronavirus (Severe acute respirotary syndrome-coronavirüs-2, previously known as 2019-nCoV), coronavirus disease 2019 (COVID-19), appeared in December 2019 and then has spread rapidly throughout the world starting from China, Japan and South Korea. As of...
Main Authors: | Mustafa GÖKÇE, Eray Metin GÜLER |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2020-12-01
|
Series: | Bezmiâlem Science |
Subjects: | |
Online Access: |
http://bezmialemscience.org/archives/archive-detail/article-preview/an-overview-of-covd-19-medicines-in-current-guidel/42780
|
Similar Items
-
COVID-19: Ivermectin; Molecular Mechanisms, Limitations, Suggestions
by: Mustafa KESMEN, et al.
Published: (2020-12-01) -
Antiviral drugs and vaccines currently used for COVID-19
by: Łukasz Dobrek
Published: (2023-12-01) -
Evaluation of Current Therapies for COVID-19 Treatment
by: Atin Sethi, et al.
Published: (2020-07-01) -
Phylodynamic analysis in the understanding of the current COVID-19 pandemic and its utility in vaccine and antiviral design and assessment
by: Jaime A. Cardona-Ospina, et al.
Published: (2021-08-01) -
Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset—Lessons Learned
by: Lars Dölken, et al.
Published: (2021-05-01)